BNTC · Benitec Biopharma Inc. Common Stock
View on chartInsiders & Stakes
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,848,156 Shares held | 12/29/2025 | View profile |
| Oliveira Steven Michael 10% Owner | ▲ Buy | Open Market | 1,000,000 Shares held | 12/9/2021 | View profile |
| J. Kevin Buchi Director | ▼ Sell | Gift | 52,097 Shares held | 6/29/2026 | View profile |
| Megan Boston Executive Director | ▲ Buy | Open Market | 25,907 Shares held | 8/11/2023 | View profile |
Transaction History
| J. Kevin Buchi | ▼ Sell | Gift | 51,813 | $0 | 6/29/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 65,800 | $884K | 12/29/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 11,587 | $156K | 12/29/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 2,516 | $33K | 12/26/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 14,320 | $188K | 12/26/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 42,600 | $547K | 12/23/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 7,400 | $95K | 12/23/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 16,650 | $201K | 12/22/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 2,892 | $35K | 12/22/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 13,950 | $160K | 12/19/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 2,434 | $28K | 12/19/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 8,700 | $98K | 12/18/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,515 | $17K | 12/18/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 730,370 | $9.9M | 11/7/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 751,111 | $10.1M | 11/7/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 9,503 | $120K | 3/31/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,267 | $16K | 3/31/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 5,057 | $67K | 3/31/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 670 | $9K | 3/31/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 793,800 | $10.3M | 3/26/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 106,200 | $1.4M | 3/26/2025 |
| J. Kevin Buchi | ▼ Sell | Gift | 103,626 | $0 | 3/12/2025 |
| J. Kevin Buchi | ▼ Sell | Gift | 103,626 | $0 | 3/12/2025 |
| J. Kevin Buchi | ▲ Buy | Option Exercise | 51,813 | $200K | 2/27/2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 17,730 | $199K | 12/24/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 2,288 | $26K | 12/24/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 24,360 | $267K | 12/23/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 3,142 | $34K | 12/23/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 37,190 | $357K | 12/3/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 4,810 | $46K | 12/3/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 24,360 | $249K | 11/20/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 3,076 | $31K | 11/20/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 12,430 | $121K | 11/19/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,570 | $15K | 11/19/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 588,236 | $1.1M | 9/26/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 4,605,000 | $17.8M | 9/26/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 1,219,970 | $122 | 9/26/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 576,347 | $2.2M | 9/26/2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 148,210 | $15 | 9/26/2024 |
| Megan Boston | ▲ Buy | Open Market | 25,907 | — | 8/11/2023 |
| J. Kevin Buchi | ▲ Buy | Open Market | 51,813 | — | 8/11/2023 |
| Oliveira Steven Michael | ▲ Buy | Open Market | 10,553 | $32K | 12/9/2021 |
| Oliveira Steven Michael | ▲ Buy | Open Market | 37,947 | $121K | 11/29/2021 |
| Oliveira Steven Michael | ▲ Buy | Open Market | 40,500 | $172K | 5/3/2021 |
| Oliveira Steven Michael | ▲ Buy | Open Market | 120,000 | $502K | 4/30/2021 |
| Oliveira Steven Michael | ▲ Buy | Open Market | 22,877 | $126K | 4/29/2021 |
| Oliveira Steven Michael | ▲ Buy | Open Market | 100,000 | $545K | 4/28/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Benitec Biopharma shares fell 23.9% over four weeks
Benitec Biopharma's stock dropped 23.9% over the past four weeks, according to a recent Yahoo article. The piece outlines factors that could help the price recover, noting the low RSI of 26.9 and the stock's proximity to a well‑tested support level at $10.89. The company’s average analyst target is $24.33, well above its current range.
Benitec Biopharma shares fell 23.9% over four weeks. Benitec Biopharma's stock dropped 23.9% over the past four weeks, according to a recent Yahoo article. The piece outlines factors that could help the price recover, noting the low RSI of 26.9 and the stock's proximity to a well‑tested support level at $10.89. The company’s average analyst target is $24.33, well above its current range.